Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4627-4634
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4627
Table 1 Baseline clinical characteristics of hepatocellular carcinoma patients treated by curative resection alone or by resection followed by transarterial chemoembolization
VariableBefore propensity score matching
After propensity score matching
TACE (n = 91)Control (n = 138)P valueTACE (n = 61)Control (n = 61)P value
Gender
Male791200.97550510.810
Female12181110
Age, yr49.8 ± 10.049.0 ± 12.50.58550.1 ± 11.050.8 ± 11.00.693
BMI, kg/m2
< 2348990.00341420.846
≥ 2343392019
HbsAg
Positive761190.57250520.625
Negative1519119
Family history of HCC
Yes21290.71213120.823
No701094849
Total bilirubin, μmol/L14.1 ± 6.914.0 ± 6.70.95013.4 ± 5.914.2 ± 7.40.451
Total serum protein, g/L69.1 ± 6.069.7 ± 6.60.51069.7 ± 6.270.0 ± 6.30.783
Albumin, g/L41.2 ± 3.939.9 ± 5.10.04240.1 ± 4.240.9 ± 4.20.675
ALT, U/L38 (10-192)35 (9-341)0.57238 (24-53)33 (23-49)0.536
AST, U/L35 (16-181)38 (17-410)0.50736 (30-50)36 (29-51)0.903
Prothrombin time, s12.5 ± 1.613.1 ± 1.70.01012.6 ± 1.412.6 ± 1.50.716
Platelet count, 109/L181.1 ± 69.2173.2 ± 78.80.436183.8 ± 73.1174.2 ± 70.80.401
AFP, ng/mL
< 40073980.11742450.548
≥ 40018401916
Tumor size, cm5.6 ± 3.06.2 ± 2.90.1555.8 ± 2.85.8 ± 2.90.932
Tumor number
167990.75444460.681
2 or 324391715
Liver cirrhosis
Positive781020.03351511.000
Negative13361010
Antiviral therapies
Yes761190.57250520.625
No1519119
Resection
Anatomic39600.92626250.854
Nonanatomic52783536
Vascular occlusion
No22230.18414110.111
Pringle maneuver42802940
Hemihepatic27351810
Surgical margins, cm
≥ 1651060.35944410.691
< 126321719
Blood loss, mL300 (200-500)300 (200-500)0.119300 (200-500)300 (175-500)0.726
Blood transfusion
Yes17380.12512130.823
No741004948
Tumor capsule
Complete59630.00436350.854
Incomplete32752526
Edmondson grade
I or II37600.67326280.715
III or IV54783533
BCLC stage
A681000.70546470.832
B23381514